Table 1.
Baseline characteristics of the study population
| n = 195 | |
|---|---|
| Demographics | |
| Age, years | 55 ± 13 |
| Male gender, n (%) | 96 (49) |
| Body mass index, kg/m2 | 24.8 ± 3.7 |
| Dyslipidemia, n (%) | 50 (26) |
| Smoking, n (%) | 21 (11) |
| Medications | |
| RAAS blockers, n (%) | 108 (55) |
| Beta blockers, n (%) | 39 (20) |
| Calcium channel blockers, n (%) | 68 (35) |
| Diuretics, n (%) | 19 (10) |
| Hemodynamics | |
| Peripheral SBP, mmHg | 148 ± 76 |
| Peripheral DBP, mmHg | 83 ± 13 |
| Peripheral PP, mmHg | 61 ± 15 |
| Central SBP, mmHg | 132 ± 18 |
| Central DBP, mmHg | 85 ± 13 |
| Central PP, mmHg | 48 ± 14 |
| AIx@75, % | 24 ± 12 |
| Heart rate, bpm | 68 ± 12 |
| PP amplification | 1.31 ± 0.21 |
| PWV, m/s | 8.3 ± 1.8 |
| Aldosterone, ng/dL | 16.03 (12.15–19.53) |
| Renin, ng/mL/h | 1.55 (0.68–3.71) |
RAAS renin angiotensin aldosterone system, SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, AIx augmentation index, PWV pulse wave velocity